Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peptiva
- Development stage
- Unknown
- Lead developer
- Adaptive Health
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Administration
- Oral
01
Overview
Peptiva is a multi-ingredient dietary supplement designed to support both digestive health and sleep quality by targeting the gut-brain axis. It combines a clinically validated probiotic matrix with a blend of sleep-inducing compounds. The probiotic component typically includes strains such as *Lactobacillus acidophilus* (DDS-1), *Bifidobacterium animalis* (Lactis), *Bifidobacterium bifidum*, and *Bifidobacterium longum*, which work to balance the gut microbiome, reduce bloating, and support intestinal comfort. The sleep support component features melatonin, a hormone that regulates the circadian rhythm, alongside gamma-aminobutyric acid (GABA) and herbal extracts like valerian root and hops, which promote relaxation and faster sleep onset. Developed by Adaptive Health, Peptiva is marketed as a once-daily nighttime supplement to provide dual-action support for restorative sleep and gastrointestinal wellness.
- Brand names
- Peptiva
- Other names
- Peptiva Sleep SupportPeptiva Probiotics + Sleep Support
02
Targets
GABAA (Gamma-aminobutyric acid receptor)MTNR1A (MT1)
Beyond the preview
Go deeper on Peptiva.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peptiva.